Do the Efficacy and Safety of Treatment with Landiolol, an Ultra-short-acting β1-Selective Blocker, Differ in the Urgent Management of Rapid Atrial Fibrillation between Patients Complicated with Cardiac Versus Non-cardiac Disease?
Do the Efficacy and Safety of Treatment with Landiolol, an Ultra-short-acting β1-Selective Blocker, Differ in the Urgent Management of Rapid Atrial Fibrillation between Patients Complicated with Cardiac Versus Non-cardiac Disease?
复制标题
兰地洛尔（一种超短效 β1 选择性阻滞剂）治疗患有心脏疾病和非心脏疾病的快速心房颤动的紧急治疗的疗效和安全性是否有所不同？
DOI：
--
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Imamura H
中科院分区：
文献类型：
--
作者：
Kamijo H;Kashima Y;Takeshige K;Nitta K;Imamura H
